Space radiation was linked to neurological damage and behavioral deficits which raised concerns of increased degenerative risk on the brain and development of Alzheimer’s disease following space travel.
Objective:
In this study, we investigated the effects of irradiation by 56Fe and 28Si in CRND8 mice, an Alzheimer’s disease mouse model.
Methods:
Six-month-old CRND8 mice were exposed to whole body irradiation by 56Fe and 28Si at 0.5 Gy and 2 Gy doses. Behavior tests were administered 1-month to 3-months post-irradiation. Amyloid deposition and other pathological changes were analyzed 3-months and/or 6-months post-irradiation.
Results:
The Novel Object Recognition test showed some decline in 8-month-old mice compared to non-irradiated CRND8 mice. Male mice also showed a loss of freezing behavior in the fear conditioning contextual test following irradiation. Golgi staining revealed a loss of spines in hippocampal neurons after irradiation. Total amyloid immunohistochemistry showed a robust increase in 3-months post-irradiation 56Fe groups which became normalized to non-irradiated group by 6-months post-irradiation. However, 2 Gy 28Si caused a trend towards increased plaque load at 3-months post-irradiation which became significant at 6-months post irradiation only in male CRND8 mice. While 0.5 Gy Fe did not induce obvious changes in the total number of iba-1 positive microglia, more hippocampal microglia were found to express PCNA after 0.5 Gy Fe treatment, suggesting potential involvement of microglial dysfunction.
Conclusions:
Overall, our study provides new evidence of gender-specific and ion-dependent effects of space radiation on cognition and amyloid pathology in AD models.
RichardsT and BudingerTF. NMR imaging and spectroscopy of the mammalian central nervous system after heavy ion radiation. Radiat Res1988; 113: 79–101.
2.
JosephJA, Villalobos-MolinaR, RabinBM, et al. Reductions of 56Fe heavy-particle irradiation-induced deficits in striatal muscarinic receptor sensitivity by selective cross-activation/inhibition of second-messenger systems. Radiat Res1994; 139: 60–66.
3.
BrittenRA, DavisLK, JohnsonAM, et al. Low (20 cGy) doses of 1GeV/u (56)Fe–particle radiation lead to a persistent reduction in the spatial learning ability of rats. Radiat Res2012; 177: 146–151.
4.
SimmonsP, TrujilloM, McElroyT, et al. Evaluating the effects of low-dose simulated galactic cosmic rays on murine hippocampal-dependent cognitive performance. Front Neurosci2022; 16: 908632.
5.
HuntWA, DaltonTK, JosephJA, et al. Reduction of 3-methoxytyramine concentrations in the caudate nucleus of rats after exposure to high-energy iron particles: evidence for deficits in dopaminergic neurons. Radiat Res1990; 121: 169–174.
6.
JosephJA, EratS and RabinBM. CNS effects of heavy particle irradiation in space: behavioral implications. Adv Space Res1998; 22: 209–216.
7.
RabinBM, JosephJA and Shukitt-HaleB. Heavy particle irradiation, neurochemistry and behavior: thresholds, dose-response curves and recovery of function. Adv Space Res2004; 33: 1330–1333.
8.
RabinBM, JosephJA and Shukitt-HaleB. A longitudinal study of operant responding in rats irradiated when 2 months old. Radiat Res2005; 164: 552–555.
9.
LoweXR, BhattacharyaS, MarchettiF, et al. Early brain response to low-dose radiation exposure involves molecular networks and pathways associated with cognitive functions, advanced aging and Alzheimer’s disease. Radiat Res2009; 171: 53–65.
10.
VillasanaL, PoageC, van MeerP, et al. Passive avoidance learning and memory of 56Fe sham-irradiated and irradiated human apoE transgenic mice. Radiats Biol Radioecol2008; 48: 167–170.
11.
VillasanaL, AcevedoS, PoageC, et al. Sex- and APOE isoform-dependent effects of radiation on cognitive function. Radiat Res2006; 166: 883–891.
12.
VlkolinskyR, TitovaE, KruckerT, et al. Exposure to 56Fe-particle radiation accelerates electrophysiological alterations in the hippocampus of APP23 transgenic mice. Radiat Res173: 342–352.
13.
CherryJD, LiuB, FrostJL, et al. Galactic cosmic radiation leads to cognitive impairment and increased abeta plaque accumulation in a mouse model of Alzheimer’s disease. PLoS One2012; 7: e53275.
14.
SchroederMK, LiuB, HinshawRG, et al. Long-term sex- and genotype-specific effects of (56)Fe irradiation on wild-type and APPswe/PS1dE9 transgenic mice. Int J Mol Sci2021; 22: 13305.
15.
LiuB, HinshawRG, LeKX, et al. Space-like (56)Fe irradiation manifests mild, early sex-specific behavioral and neuropathological changes in wildtype and Alzheimer’s-like transgenic mice. Sci Rep2019; 9: 12118.
16.
HinshawRG, SchroederMK, CiolaJ, et al. High-energy, whole-body proton irradiation differentially alters long-term brain pathology and behavior dependent on sex and Alzheimer’s disease mutations. Int J Mol Sci2023; 24: 3615.
17.
RudobeckE, BelloneJA, SzucsA, et al. Low-dose proton radiation effects in a transgenic mouse model of Alzheimer’s disease - Implications for space travel. PLoS One2017; 12: e0186168.
18.
WangS, LaiX, DengY, et al. Correlation between mouse age and human age in anti-tumor research: Significance and method establishment. Life Sci2020; 242: 117242.
19.
RobertsRO, AakreJA, KremersWK, et al. Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting. JAMA Neurol2018; 75: 970–979.
20.
LueptowLM. Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp2017: 55718.
21.
TropeaMR, SanfilippoG, GianninoF, et al. Innate preferences affect results of object recognition task in wild type and Alzheimer’s disease mouse models. J Alzheimers Dis2022; 85: 1343–1356.
22.
BussiereT, BardF, BarbourR, et al. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am J Pathol2004; 165: 987–995.
23.
CrasP, KawaiM, LoweryD, et al. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A1991; 88: 7552–7556.
24.
ZhaoF, XuY, GaoS, et al. METTL3-dependent RNA m(6)A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events. Mol Neurodegener2021; 16: 70.
25.
WangW, ZhaoF, LuY, et al. Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in Alzheimer’s disease brain. Acta Neuropathol Commun2023; 11: 54.
26.
ColemanP, FederoffH and KurlanR. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology2004; 63: 1155–1162.
27.
TerryRD, MasliahE, SalmonDP, et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol1991; 30: 572–580.
28.
DeKoskyST and ScheffSW. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol1990; 27: 457–464.
29.
SelkoeDJ. Alzheimer’s disease is a synaptic failure. Science2002; 298: 789–791.
30.
SmithMG, KelleyM and BasnerM. A brief history of spaceflight from 1961 to 2020: An analysis of missions and astronaut demographics. Acta Astronaut2020; 175: 290–299.
31.
HannaA, IremongerK, DasP, et al. Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis. Alzheimers Res Ther2012; 4: 21.
32.
OwlettL, BelcherEK, Dionisio-SantosDA, et al. Space radiation does not alter amyloid or tau pathology in the 3xTg mouse model of Alzheimer’s disease. Life Sci Space Res (Amst)2020; 27: 89–98.
33.
HuangY, HapponenKE, BurrolaPG, et al. Microglia use TAM receptors to detect and engulf amyloid beta plaques. Nat Immunol2021; 22: 586–594.
34.
HuangY, LiuB, SinhaSC, et al. Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders. Mol Neurodegener2023; 18: 79.
35.
WangW, YinJ, MaX, et al. Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model. Hum Mol Genet2017; 26: 4118–4131.
36.
ThomasAL, LehnMA, JanssenEM, et al. Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease. Sci Rep2022; 12: 19471.
37.
HouY, WeiY, LautrupS, et al. NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer’s disease via cGAS-STING. Proc Natl Acad Sci U S A2021; 118.
38.
Kerry O’BanionM. Microglia: Rheostats of space radiation effects in the CNS microenvironment. Life Sci Space Res (Amst)2022; 35: 180–186.
39.
SumanS, RodriguezOC, WintersTA, et al. Therapeutic and space radiation exposure of mouse brain causes impaired DNA repair response and premature senescence by chronic oxidant production. Aging (Albany NY)2013; 5: 607–622.
40.
TonST, LaghiJR, TsaiSY, et al. Exposure to 5 cGy 28Si Particles induces long-term microglial activation in the striatum and subventricular zone and concomitant neurogenic suppression. Radiat Res2022; 198: 28–39.
41.
KokjohnTA and RoherAE. Amyloid precursor protein transgenic mouse models and Alzheimer’s disease: understanding the paradigms, limitations, and contributions. Alzheimers Dement2009; 5: 340–347.
42.
Sanchez-VaroR, Mejias-OrtegaM, Fernandez-ValenzuelaJJ, et al. Transgenic mouse models of Alzheimer’s disease: an integrative analysis. Int J Mol Sci2022; 23: 5404.
